UY37177A - DETECTION OF MICROBIAL INFECTION IN WOUNDS - Google Patents

DETECTION OF MICROBIAL INFECTION IN WOUNDS

Info

Publication number
UY37177A
UY37177A UY0001037177A UY37177A UY37177A UY 37177 A UY37177 A UY 37177A UY 0001037177 A UY0001037177 A UY 0001037177A UY 37177 A UY37177 A UY 37177A UY 37177 A UY37177 A UY 37177A
Authority
UY
Uruguay
Prior art keywords
wounds
detection
chronic
methods
infected
Prior art date
Application number
UY0001037177A
Other languages
Spanish (es)
Inventor
Andrea Heinzle
Daniel Luschnig
Michael Burnet
Eva Sigl
Clemens Gamerith
Gregor Tegl
Georg Guebitz
Original Assignee
Qualizyme Gmbh And Cokg
Acib Gmbh
Univ Of Natural Resources And Life Sciences Vienna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qualizyme Gmbh And Cokg, Acib Gmbh, Univ Of Natural Resources And Life Sciences Vienna filed Critical Qualizyme Gmbh And Cokg
Publication of UY37177A publication Critical patent/UY37177A/en

Links

Abstract

Entidades químicas para la detección de heridas, por ejemplo, heridas crónicas o heridas infectadas, incluyendo composiciones, sustratos, conjuntos de componentes, materiales para vendaje, y artículos, y sistemas que contienen dichos compuestos. Métodos para usar estas composiciones, conjuntos de componentes y sistemas en ensayos diagnósticos, y en el diagnóstico y/o detección de heridas crónicas o infectadas en base a acción enzimática sobre porciones y/o sitios de reacción específicos. Además, se describen métodos para caracterizar heridas en base a la expresión de una pluralidad de marcadores y con el uso de dicha información para trata, manejar y hacer seguimiento de pacientes que sufren de heridas crónicas o infectadas.Chemical entities for the detection of wounds, for example, chronic wounds or infected wounds, including compositions, substrates, component assemblies, bandage materials, and articles, and systems containing said compounds. Methods for using these compositions, sets of components and systems in diagnostic tests, and in the diagnosis and / or detection of chronic or infected wounds based on enzymatic action on specific portions and / or reaction sites. In addition, methods for characterizing wounds are described based on the expression of a plurality of markers and with the use of such information to treat, manage and monitor patients suffering from chronic or infected wounds.

UY0001037177A 2016-03-30 2017-03-30 DETECTION OF MICROBIAL INFECTION IN WOUNDS UY37177A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662315556P 2016-03-30 2016-03-30

Publications (1)

Publication Number Publication Date
UY37177A true UY37177A (en) 2017-10-31

Family

ID=60892344

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001037177A UY37177A (en) 2016-03-30 2017-03-30 DETECTION OF MICROBIAL INFECTION IN WOUNDS

Country Status (3)

Country Link
AR (1) AR108053A1 (en)
TW (1) TW201800753A (en)
UY (1) UY37177A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110634535A (en) * 2018-06-06 2019-12-31 中国石油化工股份有限公司 Chemical process parameter sensitivity determination method based on Monte Carlo method
CN111826334A (en) * 2020-07-24 2020-10-27 暨南大学 Ultra-long escherichia coli and preparation method and application thereof

Also Published As

Publication number Publication date
AR108053A1 (en) 2018-07-11
TW201800753A (en) 2018-01-01

Similar Documents

Publication Publication Date Title
ECSP18081954A (en) DETECTION OF MICROBIAL INFECTION IN WOUNDS
UY37176A (en) MODIFIED DRESSES FOR WOUNDS
BR112015027704A2 (en) COMPOUND, USE OF THE SAME AND ANTIBACTERIAL PHARMACEUTICAL COMPOSITION
CL2008003406A1 (en) Quinoline derived compounds; pharmaceutical composition comprising them; and use in the treatment of an HIV infection.
CL2016000493A1 (en) Hcv polymerase inhibitors
CL2017001362A1 (en) Compounds of n - ((het) arylmethyl) -heteroaryl-carboxamides as inhibitors of plasma kallikrein
BR112015007833A8 (en) pressure sensitive adhesives and liquids suitable for curing, and related use
CL2016001364A1 (en) Ror gamma modulators (rory)
CL2009000483A1 (en) Compounds derived from n- (pyridin-3-yl) -1,3-thiazole-5-amino-4-carboxamide, pim kinase inhibitors; pharmaceutical composition; and use for the treatment of cancer.
CL2008003405A1 (en) Compounds derived from thienopyridine, inhibitors of the hiv integrase enzyme; pharmaceutical composition comprising said compounds; and its use to treat an HIV infection.
CL2011000691A1 (en) Compounds derived from substituted nicotinamide; pharmaceutical composition that includes them; use for the treatment and / or prevention of cancer, infections, inflammatory and autoimmune diseases.
CL2008002430A1 (en) Benzenesulfonamide derived compounds, cathepsin c inhibitors; pharmaceutical composition comprising them; and its use for the treatment of copd.
BR102018069950A8 (en) EXTENSIVE DRESSINGS
BR112017010808A2 (en) prevention and treatment of microbial infections
CL2008002369A1 (en) Compounds derived from pyridin-3-yl-oxypyridin-2-yl-amino, alk5 inhibitors; pharmaceutical composition comprising said compound; and use of the compound in the treatment of cancer.
BR112016019592A8 (en) COMPOUND, USE OF A COMPOUND, AND, PHARMACEUTICAL COMPOSITION
BR112017005361A2 (en) opipramol plaster
BR112013000399A2 (en) method for sterilization of at least one object, sterilization apparatus and its use
BR112015017241A8 (en) compound, pharmaceutical composition, use of compound and pharmaceutical composition and kit
BR112016006994A2 (en) erk inhibitors and methods of use
CO2022000481A2 (en) enzyme inhibitors
BR112017023451A2 (en) acrylic emulsion adhesives
CR11730A (en) FUSIONED RING COMPOUNDS AND USE OF THE SAME
BR112018013327A2 (en) Application of Rimycin in Anti-tuberculosis Mycobacterium Infection
BR112016002215A2 (en) cohesive olefin block copolymer fixative formulations

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20230612